Rankin et al. [21] showed that agonist (sulprostone) and antagonist of EP3r both significantly reduced GSIS and fasting plasma glucagon in non-human primates with noninsulin-dependent diabetes mellitus. This evidence concerns the gene GCG and type 2 diabetes mellitus.